With over a decade of systems biology research, scientists have proposed a biological model that suggests autism spectrum disorders develop when three specific conditions align: genetic predisposition, environmental exposure and prolonged activation.
The “three-hit model” reframes autism as a treatable disorder of cellular communication and energy metabolism. It also suggests that as many as half of all autism cases might be prevented or reduced with prenatal and early-life interventions.
The researchers describe the three hits as:
- Genetic predisposition: Inherited genes can make mitochondria and certain cellular signaling pathways unusually sensitive to change.
- Prolonged activation: When this cellular stress response stays switched on for too long—typically because of repeated or ongoing exposure to stressors from late pregnancy through the first two to three years of life—it can interfere with normal brain development and lead to ASD.
- Early trigger: Environmental exposures—such as maternal or early infant infection, immune stress or pollution—can activate a universal cellular stress response, called the cell danger response (CDR). CDR is a metabolic process that helps cells heal from injury or infection, responds to threats and adapts to changing conditions. The CDR is normally short-lived: it turns on to promote healing and turns off once the danger has passed. However, when the response becomes chronic it can disrupt cellular communication and alter mitochondrial function.
“Behavior has a chemical basis,” said study author Robert K. Naviaux, M.D., professor of medicine, pediatrics and pathology at UC San Diego School of Medicine. “The CDR regulates that chemistry. When it remains activated too long, it diverts the body’s resources from normal growth and development toward cellular defense, leaving fewer resources for the developing brain.”
Because the environmental triggers and prolonged activation of the CDR “hits” are potentially reversible, early detection and intervention could dramatically reduce autism risk, say the researchers.
Naviaux says future research should focus on refining diagnostic tools that can detect metabolic stress before symptoms appear and on testing therapies that rebalance the body’s energy and signaling systems. The researchers specifically calls for the development of new antipurinergic drugs to regulate the abnormal ATP signaling that triggers and maintains the CDR.
Data from University of California San Diego